Enterohepatic Circulation

Bile acids are expensive to make. Each one starts as a molecule of cholesterol that the liver rebuilds through a 17-step pathway into an amphipathic detergent — a molecule with a water-loving face and a fat-loving face — that can break dietary fat into microscopic droplets the gut can absorb. Synthesizing the whole working supply from scratch every meal would be wasteful, so the body does something far more economical: it uses each bile acid molecule, recaptures it almost intact, and sends it back to the liver to be deployed again. That conservation loop is enterohepatic circulation — literally "gut-to-liver" circulation.

The loop, step by step

Follow a single bile salt molecule through one trip:

• Synthesis and conjugation. Hepatocytes convert cholesterol into the primary bile acids cholic acid and chenodeoxycholic acid. The rate-limiting step is the enzyme cholesterol 7-alpha-hydroxylase (CYP7A1). Before secretion the liver conjugates them with the amino acids glycine or taurine, which lowers their pKa so they stay ionized — as bile salts — and trapped in the gut lumen rather than passively leaking back across the membrane too early.
• Secretion and storage. The bile salt export pump (BSEP, gene ABCB11) pushes conjugated bile acids across the canalicular membrane into bile. Between meals, the sphincter of Oddi is closed and bile backs up into the gallbladder, where it is concentrated up to tenfold.
• Release into the duodenum. A fatty meal triggers cholecystokinin (CCK) release from the duodenal mucosa; CCK contracts the gallbladder and relaxes the sphincter of Oddi, ejecting concentrated bile into the small intestine.
• Emulsification. In the lumen, bile salts coat fat droplets and, together with phospholipids and cholesterol, assemble into mixed micelles. These micelles ferry fatty acids, monoglycerides, and the fat-soluble vitamins (A, D, E, K) to the brush border for absorption. Without bile salts above their critical micellar concentration, fat absorption collapses.
• Active reabsorption in the ileum. The bile salts themselves are not absorbed with the fat in the jejunum. They travel onward to the terminal ileum, where the apical sodium-dependent bile acid transporter (ASBT, gene SLC10A2) actively pumps about 95% of them back into the enterocyte. Inside the cell they bind the ileal bile acid binding protein and exit the basolateral side through the OSTα/OSTβ heterodimer into the portal blood.
• Portal return and re-uptake. The portal vein delivers the reclaimed bile acids directly to the liver — they never enter the general circulation in any appreciable amount. Hepatocytes take them up efficiently through the transporter NTCP (gene SLC10A1) on a single first pass, and the cycle repeats.

The numbers are what make the system elegant. The total bile acid pool is only about 2-4 grams, yet the gut sees 12-30 grams of bile acids per day because each molecule is reused. With six to twelve cycles daily, the liver only needs to replace the small amount that escapes capture — roughly 0.2 to 0.5 grams excreted in stool — to keep the pool constant. That fecal loss is, incidentally, the body's only meaningful route for eliminating cholesterol, because bile acids are made from it.

How tightly it is regulated

The whole loop is governed by feedback through the nuclear receptor FXR (farnesoid X receptor), the cell's bile acid sensor. When the returning bile acids activate FXR inside hepatocytes, FXR induces the repressor SHP, which switches off CYP7A1 — the liver stops making bile acids when plenty are coming back. FXR in the ileum adds a second brake: it triggers release of the endocrine hormone FGF19, which travels in the portal blood to the liver and independently suppresses CYP7A1. This dual feedback explains why the pool size is so stable: pull bile acids out of the loop and synthesis ramps up; flood the loop and synthesis shuts down.

This is also why interrupting the circulation is therapeutically useful. Block reabsorption and the liver, sensing a depleted pool, burns through cholesterol to rebuild it — the mechanism behind a whole class of cholesterol drugs, discussed below.

Not just bile acids — the loop carries passengers

The enterohepatic highway also recycles other molecules, which has large clinical consequences:

• Bilirubin. The liver conjugates bilirubin with glucuronic acid and excretes it in bile. Gut bacteria deconjugate some of it; a fraction is reabsorbed and re-excreted. This recycling matters in neonatal jaundice, where slow gut transit and bacterial enzymes increase bilirubin reabsorption.
• Drugs. Compounds conjugated in the liver and dumped into bile are often deconjugated by bacterial beta-glucuronidase in the gut and reabsorbed, producing a characteristic second peak on the plasma concentration-time curve and a longer effective half-life. Estrogens in oral contraceptives are a classic example — broad-spectrum antibiotics that kill the deconjugating bacteria can theoretically reduce recycled estrogen and contraceptive efficacy.
• Toxins. The same recycling lets clinicians intervene: multiple-dose activated charcoal traps recirculating drugs (phenobarbital, theophylline, carbamazepine, dapsone) in the gut during each pass, accelerating their removal — so-called "gut dialysis."

Clinical correlations

Because the system depends on one narrow anatomical bottleneck — the terminal ileum — and one regulated synthesis step, disease tends to attack it in predictable ways.

Terminal ileal disease or resection. Crohn's disease, radiation enteritis, or surgical removal of the terminal ileum strips out the ASBT transporters and breaks reabsorption. With a short resection the liver compensates by making more bile acids, but the spillover into the colon irritates the mucosa and drives water and electrolyte secretion — bile acid (choleretic) diarrhea, which responds dramatically to bile acid binders. With a long resection (over roughly 100 cm), synthesis can no longer keep up, the pool shrinks below the critical micellar concentration, and fat is malabsorbed — producing steatorrhea, deficiency of fat-soluble vitamins, and calcium-oxalate kidney stones (because unabsorbed fat binds calcium, freeing oxalate to be absorbed and excreted).

Cholestasis. If bile flow is blocked (gallstones, primary biliary cholangitis, drug injury), bile acids back up into hepatocytes and blood, causing the intense itch (pruritus) of cholestatic disease. Therapies target the loop directly: ursodeoxycholic acid enriches the pool with a less toxic bile acid; FXR agonists like obeticholic acid recruit the natural feedback brakes; and newer ileal ASBT inhibitors deliberately interrupt reabsorption to relieve itch in pediatric cholestasis.

Gallbladder removal. After cholecystectomy there is no reservoir to store concentrated bile between meals, so bile drips continuously into the gut. The loop still works, but the loss of pulsed, meal-triggered delivery and the constant low-grade flow into the colon can produce post-cholecystectomy diarrhea in a subset of patients.

Lipid lowering. Bile acid sequestrants — cholestyramine, colestipol, colesevelam — are the deliberate, therapeutic interruption of enterohepatic circulation. They are non-absorbable resins that bind bile acids in the gut and carry them out in stool. The liver, deprived of its returning pool, upregulates CYP7A1 to make new bile acids and upregulates LDL receptors to harvest the cholesterol it needs, lowering serum LDL by about 15-30%.

Healthy loop vs. broken loop

The clearest way to understand the circulation is to compare an intact loop with one that has been interrupted at the ileum.

Feature	Intact enterohepatic circulation	Interrupted loop (ileal disease/resection or sequestrant)
Bile acids reabsorbed in ileum	~95% per pass	Markedly reduced; large fraction lost to colon
Hepatic bile acid synthesis (CYP7A1)	Low — replaces only ~0.5 g/day lost	Upregulated, can rise up to ~10-fold
Bile acid pool size	Stable at 2-4 g	Shrinks if synthesis cannot keep pace
Fat absorption	Normal (micelles above critical concentration)	Impaired with long resection → steatorrhea
Serum LDL cholesterol	Baseline	Falls ~15-30% (sequestrant) as liver harvests cholesterol
Typical symptom	None	Watery (bile acid) diarrhea or steatorrhea; oxalate stones

Why enterohepatic circulation matters

• Gastroenterology. Bile acid diarrhea is a common, treatable, and frequently missed cause of chronic watery diarrhea — interrupting the loop with binders is both diagnostic and therapeutic.
• Cardiology and lipidology. Bile acid sequestrants and the FXR/FGF19 axis are direct levers on cholesterol balance and LDL.
• Surgery. The length and location of small-bowel resection predicts whether a patient develops choleretic diarrhea or full-blown fat malabsorption.
• Pharmacology. Recycling produces secondary plasma peaks, prolongs half-lives, and underlies drug-drug interactions and the use of multi-dose charcoal in poisoning.
• Neonatology. Bilirubin recycling through the same loop contributes to physiologic and breastfeeding jaundice.
• Hepatology. FXR agonists and ileal ASBT inhibitors are an active frontier for cholestatic liver disease and NASH.

Common misconceptions

• "Bile salts are absorbed along with the fat." They are not — fat is absorbed in the jejunum while bile salts travel on to be reclaimed specifically in the terminal ileum, then released to do their job again.
• "The liver makes all its bile acids fresh each day." It replaces only the small fraction lost in stool; the bulk is recycled, which is the entire point of the loop.
• "Reabsorbed bile acids enter the general bloodstream." They return through the portal vein and are extracted by the liver on first pass, so systemic blood levels stay very low in health.
• "Removing the gallbladder stops bile acid recycling." The loop continues; only the storage-and-pulse function is lost, so bile flows more continuously.
• "Bile acid sequestrants work by blocking cholesterol absorption." They bind bile acids; the LDL drop is an indirect consequence of the liver upregulating LDL receptors to make replacement bile acids.

This article is educational and is not medical advice. For diagnosis or treatment of any condition, consult a qualified clinician.